Oliva, M., Vidales, Z., Llop-Serna, S., Arrazubi, V., Cirauqui, B., Bruixola, G., Braña, I., Docampo, L. I., Mazariegos, M., Goma, M., Linares, I., Bel, L. R., Durán, M., Montalbán, C., Cacicedo, J., Marruecos, J., Navarro, V., Giralt, J., Lozano, A., Mesia, R. (2026). Niraparib and dostarlimab in locally advanced head and neck squamous cell carcinoma (LA-HNSCC) treated with (chemo)radiotherapy (CRT): Results from the phase IB-II TTCC-2022-01 RADIAN trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.6096